Quantitative structure-activity relationships of cytochrome P-450.

(1993). Quantitative Structure-Activity Relationships of Cytochrome P-450. Drug Metabolism Reviews: Vol. 25, No. 1-2, pp. 1-48.

[1]  A. Debnath,et al.  Mutagenicity of quinolines in Salmonella typhimurium TA100. A QSAR study based on hydrophobicity and molecular orbital determinants. , 1992, Mutation research.

[2]  H. Rosenkranz,et al.  Use of artificial intelligence in structure-affinity correlations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) receptor ligands. , 1991, Carcinogenesis.

[3]  M. J. Coon,et al.  Cytochrome P-450 : multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms , 1991 .

[4]  F. Guengerich.  Reactions and significance of cytochrome P-450 enzymes. , 1991, The Journal of biological chemistry.

[5]  M. J. Coon,et al.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. , 1991, DNA and cell biology.

[6]  A. Debnath,et al.  Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity. , 1991, Journal of medicinal chemistry.

[7]  A. Debnath,et al.  Mutagenicity of dimethyl heteroaromatic triazenes in the Ames test: the role of hydrophobicity and electronic effects. , 1989, Molecular pharmacology.

[8]  J. Gustafsson,et al.  Interactions of rutaecarpine alkaloids with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. , 1989, Carcinogenesis.

[9]  R. Martin,et al.  Oxidation of substituted N,N-dimethylanilines by cytochrome P-450: estimation of the effective oxidation-reduction potential of cytochrome P-450. , 1989, Biochemistry.

[10]  T. Fujita,et al.  Induction of rat liver microsomal cytochrome P-450 isozymes and epoxide hydrolase by a series of 4'-substituted-2,3,4,5-tetrachlorobiphenyls. , 1988, Toxicology.

[11]  T. Fujita,et al.  Quantitative structure-activity relationships: analysis of interactions of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2-substituted analogues with rat, mouse, guinea pig, and hamster cytosolic receptor. , 1987, Cancer research.

[12]  A. Leo,et al.  Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. , 1987, Journal of pharmaceutical sciences.

[13]  C. Hansch,et al.  Molecular graphics and QSAR in the study of enzyme-ligand interactions. On the definition of bioreceptors , 1986 .

[14]  C. Ioannides,et al.  Induction of cytochrome P-448 activity as exemplified by the O-deethylation of ethoxyresorufin. Effects of dose, sex, tissue and animal species. , 1986, Biochemical pharmacology.

[15]  R. E. White,et al.  Active site mechanics of liver microsomal cytochrome P-450. , 1986, Archives of biochemistry and biophysics.

[16]  C. Hansch,et al.  Induction of cytochrome P-450 by alcohols and 4-substituted pyrazoles. Comparison of structure-activity relationships. , 1986, Biochemical pharmacology.

[17]  T. Fujita,et al.  Substituted polychlorinated dibenzofuran receptor binding affinities and aryl hydrocarbon hydroxylase induction potencies--a QSAR analysis. , 1986, Chemico-biological interactions.

[18]  A. Hopfinger.  Computer-assisted drug design. , 1985, Journal of medicinal chemistry.

[19]  T. Fujita,et al.  Effects of substituents on the cytosolic receptor-binding avidities and aryl hydrocarbon hydroxylase induction potencies of 7-substituted 2,3-dichlorodibenzo-p-dioxins. A quantitative structure-activity relationship analysis. , 1985, Molecular pharmacology.

[20]  M. Romkes,et al.  Polychlorinated dibenzofurans (PCDFs): effects of structure on binding to the 2,3,7,8-TCDD cytosolic receptor protein, AHH induction and toxicity. , 1984, Toxicology.

[21]  D. Newell,et al.  Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity. , 1984, Journal of medicinal chemistry.

[22]  T. Fujita,et al.  Competitive binding to the cytosolic 2,3,7,8-tetrachlorodibenzo-p-dioxin receptor. Effects of structure on the affinities of substituted halogenated biphenyls--a QSAR analysis. , 1983, Biochemical pharmacology.

[23]  L. Pedersen,et al.  The polarizability of planar aromatic systems. An application to polychlorinated biphenyls (PCB's), dioxins and polyaromatic hydrocarbons , 1983 .

[24]  J. Holtzman,et al.  Role of substrate lipophilicity on the N-demethylation and type I binding of 3-O-alkylmorphine analogues. , 1983, Journal of medicinal chemistry.

[25]  D Mackay,et al.  Correlation of bioconcentration factors. , 1982, Environmental science & technology.

[26]  J. Bridges,et al.  The relationship between binding to cytochrome P-450 and metabolism of n-alkyl carbamates in isolated rat hepatocytes. , 1982, Biochemical pharmacology.

[27]  S. Safe,et al.  Binding of polychlorinated biphenyls classified as either phenobarbitone-, 3-methylcholanthrene- or mixed-type inducers to cytosolic Ah receptor. , 1982, Chemico-biological interactions.

[28]  J. Bridges,et al.  The role of substrate lipophilicity in determining type 1 microsomal P450 binding characteristics. , 1978, Biochemical pharmacology.

[29]  J. Bridges,et al.  The dealkylation of some p-nitrophenylalkylethers and their α-deuterated analogues by rat liver microsomes , 1975 .

[30]  C. F. Wilkinson,et al.  Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivo. , 1974, Biochemical pharmacology.

[31]  W. Dunn,et al.  Chemicobiological interactions and the use of partition coefficients in their correlation. , 1974, Chemico-biological interactions.

[32]  J. R. Carl,et al.  Atom dipole interaction model for molecular polarizability. Application to polyatomic molecules and determination of atom polarizabilities , 1972 .

[33]  C. Hansch.  Quantitative approach to biochemical structure-activity relationships , 1969 .

[34]  R. Estabrook,et al.  Spectral studies of drug interaction with hepatic microsomal cytochrome. , 1967, Molecular pharmacology.

[35]  D. Holtzman,et al.  The action of anesthetics on excitable membranes: a quantum-chemical analysis. , 1965, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Mcmahon,et al.  Dimethylation Studies--III. The in vitro Demethylation of Dialkylmethylamines , 1961 .

[37]  B. Brodie,et al.  Relationship between the lipid solubility of drugs and their oxidation by liver microsomes. , 1959, Biochemical pharmacology.

[38]  David Pressman,et al.  The Serological Properties of Simple Substances. IX. Hapten Inhibition of Precipitation of Antisera Homologous to the o-, m-, and p-Azophenylarsonic Acid Groups , 1945 .

[39]  L Zhang,et al.  The structure-activity relationship of skin carcinogenicity of aromatic hydrocarbons and heterocycles. , 1992, Chemico-biological interactions.

[40]  A. Debnath,et al.  Quantitative structure‐activity relationship investigation of the role of hydrophobicity in regulating mutagenicity in the Ames test: 2. Mutagenicity of aromatic and heteroaromatic nitro compounds in Salmonella typhimurium TA100 , 1992, Environmental and molecular mutagenesis.

[41]  Albert J. Leo,et al.  [25] Hydrophobic parameter: Measurement and calculation , 1991 .

[42]  C. Hansch,et al.  Quantitative structure-activity relationships and molecular graphics in evaluation of enzyme-ligand interactions. , 1991, Methods in enzymology.

[43]  C. Hansch,et al.  Induction of Cytochrome P450 by Barbiturates in Chick Embryo Hepatocytes: A Quantitative Structure-Activity Analysis , 1990 .

[44]  A. Okey.  Enzyme induction in the cytochrome P-450 system. , 1990, Pharmacology & therapeutics.

[45]  J. Gustafsson,et al.  Quantitative Structure‐Activity Relationship (QSAR) Analysis Using the Partial Least Squares (PLS) Method: The Binding of Polycyclic Aromatic Hydrocarbons (PAH) to the Rat Liver 2,3,7,8‐Tetrachlorodibenzo‐P‐Dioxin (TCDD) Receptor , 1989 .

[46]  E Novellino,et al.  Toward a quantitative comparative toxicology of organic compounds. , 1989, Critical reviews in toxicology.

[47]  Lee G. Pedersen,et al.  Polychlorinated dibenzofuran (PCDF) binding to the Ah receptor(s) and associated enzyme induction. Theoretical model based on molecular parameters , 1987 .

[48]  J. Depierre,et al.  Induction of different isozymes of cytochrome P-450 and of microsomal epoxide hydrolase in rat liver by 2-acetylaminofluorene and structurally related compounds. , 1986, European journal of biochemistry.

[49]  P. R. Montellano.  Cytochrome P-450 , 1986, Springer US.

[50]  J. Murray,et al.  Comparative analysis of the electrostatic potentials of dibenzofuran and some dibenzo p dioxins , 1986 .

[51]  C. Ioannides,et al.  Interactions of safrole and isosafrole and their metabolites with cytochromes P-450. , 1985, Chemico-biological interactions.

[52]  C. Ioannides,et al.  Cytochrome P-448 and the activation of toxic chemicals and carcinogens. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.

[53]  L. Pedersen,et al.  PCB and Dioxin Binding to Cytosol Receptors: A Theoretical Model Based on Molecular Parameters , 1984 .

[54]  Albert J. Leo,et al.  The octanol–water partition coefficient of aromatic solutes: the effect of electronic interactions, alkyl chains, hydrogen bonds, and ortho-substitution , 1983 .

[55]  P. Little,et al.  Inhibitors of hepatic mixed-function oxidases. 4. Effects of benzimidazole and related compounds on aryl hydrocarbon hydroxylase activity from phenobarbitone and 3-methylcholanthrene induced rats. , 1982, Journal of medicinal chemistry.

[56]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[57]  W J Dunn,et al.  Linear relationships between lipophilic character and biological activity of drugs. , 1972, Journal of pharmaceutical sciences.

[58]  C. Hansch.  Quantitative Relationships Between Lipophilic Character and Drug Metabolism , 1972 .

[59]  B. Brodie,et al.  Enzymatic metabolism of drugs and other foreign compounds. , 1958, Annual review of biochemistry.